Nishant Shah, MD
Cardiovascular Disease · Durham, NCNPI 1457601106
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $48,098 of the $56,523 with a category attached, or 85.1%. 13 manufacturers reported payments, led by Novartis at 53.5% of the total. 2025 is the largest year on record at $22,142, 7.2 times the $3,083 reported in 2021. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $796.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$30K
- Amgen$5K
- Regeneron Healthcare Solutions, Inc.$5K
- Premier Healthcare Solutions, Inc.$4K
- Regeneron$4K
- Merck$3K
- plus $5K from 7 others
Across 38 payments — averaging $91,745 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$3.2M
- Novartis$226K
- Alnylam Pharmaceuticals Inc.$81K
- Eli Lilly$132
What the payments were for
- Consulting fees$48,09885%
- Speaking & faculty fees$2,8405%
- Travel & lodging$2,4904%
- Food & beverage$3,0955%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 23 | $30,222 |
| Amgen | 11 | $5,297 |
| Regeneron Healthcare Solutions, Inc. | 9 | $4,661 |
| Premier Healthcare Solutions, Inc. | 2 | $4,225 |
| Regeneron | 4 | $3,870 |
| Merck | 4 | $3,063 |
| Esperion Therapeutics, Inc. | 3 | $2,965 |
| Alnylam Pharmaceuticals Inc. | 8 | $1,576 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $198 |
| Astrazeneca UK Limited | 1 | $135 |
| Abiomed | 1 | $131 |
| Abbott | 1 | $109 |
| AstraZeneca | 2 | $71 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$56,523 in reported general payments places this provider in the 90th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 181 | $169,689 |
| Praluent PenAlirocumab | 46 | $48,594 |
| OzempicSemaglutide | 20 | $39,074 |
| JardianceEmpagliflozin | 25 | $32,594 |
| EliquisApixaban | 14 | $21,970 |
| Repatha SyringeEvolocumab | 16 | $11,388 |
| Ezetimibe | 96 | $2,565 |
| Atorvastatin Calcium | 98 | $1,513 |
| Rosuvastatin Calcium | 107 | $1,040 |
| Metoprolol Succinate | 39 | $664 |
| Amlodipine Besylate | 59 | $417 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 19 | $308 |
| Lisinopril | 29 | $266 |
| Hydralazine Hcl | 17 | $226 |
| Losartan Potassium | 27 | $182 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Durham
- R WilliamsDurham$2.1M
- Marat FudimDurham$902K
- Jonathan PicciniDurham$767K
- Robert MentzDurham$489K
- Adrian HernandezDurham$409K
- Neha PagidipatiDurham$301K
- Joseph KissloDurham$283K
- Mitchell KrucoffDurham$281K
- Ankeet BhattDurham$258K
- Christopher GrangerDurham$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.